 |
|
Cognitive impairment link found in older adults taking popular stomach acid medications
August 06, 2007INDIANAPOLIS - Long-term use of histamine2 receptor antagonists (H2A), one class of drugs that blocks stomach acid, may be associated with cognitive impairment in older African-American adults. According to an Indiana University School of Medicine and Regenstrief Institute study published in the August issue of the Journal of the American Geriatrics Society, the risk for showing signs of cognitive impairment is 2.5 times greater for patients using these medications long-term.
These acid blockers, including ranitidine and famotidine, are among the most popular medications prescribed in the United States. More than 16 million prescriptions were dispensed in 2005 and several of these medications are also available over-the-counter. The drugs are sold under brand names such as Axid, Pepcid, Tagamet and Zantac, and are used to treat ulcers, acid reflux and other gastrointestinal disorders.
The five-year observational study included 1,558 cognitively normal African-Americans aged 65 and older. After controlling for other possible factors, nearly 18 percent of H2A users studied exhibited signs of cognitive impairment.
"Taking these medications continuously appears to put older African-Americans at greater risk for the development of cognitive impairment," said Malaz Boustani, M.D., MPH, assistant professor of medicine at the IU School of Medicine and a Regenstrief research scientist. Dr. Boustani is lead author of the study. "We need to study this further to determine how acid blockers might be causing or creating this effect and if it occurs only in African-Americans."
Indiana University
"Taking these medications continuously appears to put older African-Americans at greater risk for the development of cognitive impairment," said Malaz Boustani, M.D., MPH, assistant professor of medicine at the IU School of Medicine and a Regenstrief research scientist. Dr. Boustani is lead author of the study. "We need to study this further to determine how acid blockers might be causing or creating this effect and if it occurs only in African-Americans."
Indiana University
Cognitive Impairment Current Events and Cognitive Impairment News RSSRapid Screening Test Developed to Detect Early Alzheimer's Disease
With millions of baby boomers entering late adulthood, the number of patients with Alzheimer's disease (AD) is expected to drastically rise over the next several decades.
Getting lost -- a newly discovered developmental brain disorder
Feeling lost every time you leave your home? You may not be as alone as you think.
Genetic Variants Associated with Vitamin B12
Researchers at the Harvard School of Public Health (HSPH) and their collaborators at Tufts University and the National Cancer Institute (NCI) have identified a common genetic influence on B12 vitamin levels in the blood, suggesting a new way to approach the biological connections between an important biochemical variable and deficiency-related diseases.
Rhode Island Hospital study finds link between obesity, type 2 diabetes and neurodegeneration
New research from Rhode Island Hospital found that obesity and Type 2 Diabetes Mellitus (T2DM) can contribute to mild neurodegeneration with features common with Alzheimer's disease (AD) - the first study to show that obesity can cause neurodegeneration.
Age-related memory loss tied to slip in filtering information quickly
Scientists have identified a way in which the brain's ability to process information diminishes with age, and shown that this break down contributes to the decreased ability to form memories that is associated with normal aging.
Study finds B-vitamin deficiency may cause vascular cognitive impairment
A deficiency of B-vitamins may cause vascular cognitive impairment, according to a new study. Researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University used an experimental model to examine the metabolic, cognitive, and microvascular effects of dietary B-vitamin deficiency.
Study examines testing model to predict and diagnose new cases of dementia
A report published by researchers at Albert Einstein College of Medicine of Yeshiva University in the August 20 issue of JAMA suggests that measuring how much an individual's performance varies across several neuropsychological tests enhances the accuracy of predicting whether older adults will develop dementia.
PET scans may help assess presence of brain plaques related to Alzheimer's disease
A type of positron emission tomography (PET) scanning may be useful in a non-invasive assessment of the formation of Alzheimer's disease-related plaques in the brain, according to small study posted online today that will appear in the October 2008 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cognitive problems associated with diabetes duration and severity
Individuals with mild cognitive impairment appear more likely to have earlier onset, longer duration and greater severity of diabetes, according to a report in the August issue of Archives of Neurology, one of the JAMA/Archives journals.
U of M researchers find cerebral malaria may be a major cause of brain injury in African children
Researchers at the University of Minnesota have found that cerebral malaria is related to long-term cognitive impairment in one of four child survivors. The research is published in the current issue of the journal Pediatrics.
More Cognitive Impairment Current Events and Cognitive Impairment News Articles
 | Mild Cognitive Impairment: Aging to Alzheimer's Disease (Medicine) What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's... |
 | Vascular Cognitive Impairment: Preventable Dementia In recent years there has been a radical reapprisal of the concept of vascular dementia. There has been a move away from an Alzheimer-based diagnostic paradigm towards one more appropriately tailored for vascular disease. Vascular Cognitive Impairment presents a new definition for this class of cerebrovascular, neurodegenerative process with an emphasis on early detection, prompt treatment and... |
 | Assessment of Feigned Cognitive Impairment: A Neuropsychological Perspective Comprehensive and user friendly, this book synthesizes the growing literature on symptom feigning in cognitive testing and translates it into evidence-based recommendations for clinical and forensic practice. A wide range of cognitive effort assessment techniques and strategies are critically reviewed, including both dedicated measures and the use of embedded indicators in standard clinical... |
 | Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis by Jeffrey Burns, John Morris Written by leading authorities in the field, this book describes the cognitive changes associated with age, the earliest detectable stages of Alzheimer’s, and the relationship of these conditions to MCI. The authors review the latest advances in our understanding of MCI, its prevalence, evaluation, management, and outcomes and in so doing provide practising physicians with a useful resource... |
 | Perspectives on Mild Cognitive Impairment (Studies on Neuropsychology, Neurology and Cognition) by Holly A. Tuokko, David F. Hultsch Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings... |
| 10 ways to cope with mild cognitive impairment: learning these simple strategies to help you adapt to your changing memory performance can help you minimize ... An article from: Mind, Mood & Memory by Gale Reference Team This digital document is an article from Mind, Mood & Memory, published by Thomson Gale on December 1, 2006. The length of the article is 1195 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: 10... | |
 | Animal Models of Cognitive Impairment (Frontiers in Neuroscience) The costs associated with a drug’s clinical trials are so significant that it has become necessary to validate both its safety and efficacy in animal models prior to the continued study of the drug in humans. Featuring contributions from distinguished researchers in the field of cognitive therapy research, Animal Models of Cognitive Impairment examines some of the most popular and successful... |
 | Fibromyalgia: A Comprehensive Approach What You Can Do About Chronic Pain and Fatigue by Miryam Ehrlich Williamson Patient education guide to managing the pain associated with fibromyalgia, for the lay-level reader. Discusses practical topics such as finding the right physician, which pain therapies work best, the role of exercise in symptom management, and more.... |
| Mild cognitive impairment seen in 19% of nondemented individuals over age 70. (High Risk For Alzheimer's).: An article from: Family Practice News by Miriam E. Tucker This digital document is an article from Family Practice News, published by International Medical News Group on October 1, 2002. The length of the article is 350 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Caution urged in using experimental tools to evaluate MCI.(mild cognitive impairment )(clinical trials): An article from: Clinical Psychiatry News by Patrice Wendling This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on May 1, 2006. The length of the article is 638 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:... |
| © 2008 BrightSurf.com |